RhoB, Not RhoA, Represses the Transcription of the Transforming Growth Factor β Type II Receptor by a Mechanism Involving Activator Protein 1
Authors:
Open Access
- 1 March 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (10) , 8500-8507
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Both Farnesylated and Geranylgeranylated RhoB Inhibit Malignant Transformation and Suppress Human Tumor Growth in Nude MiceJournal of Biological Chemistry, 2000
- Smad4/DPC4 Silencing and Hyperactive Ras Jointly Disrupt Transforming Growth Factor-β Antiproliferative Responses in Colon Cancer CellsJournal of Biological Chemistry, 1999
- Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFβOncogene, 1999
- Overexpression of transforming growth factor ?-type II receptor reduces tumorigenicity and metastastic potential of K-ras-transformed thyroid cellsInternational Journal of Cancer, 1999
- A Novel ets-related Transcription Factor, ERT/ESX/ESE-1, Regulates Expression of the Transforming Growth Factor-β Type II ReceptorJournal of Biological Chemistry, 1998
- Reduced Expression of Transforming Growth Factor β Type I Receptor Contributes to the Malignancy of Human Colon Carcinoma CellsJournal of Biological Chemistry, 1996
- Characterization of the Promoter Region of the Human Transforming Growth Factor-β Type II Receptor GeneJournal of Biological Chemistry, 1995
- The Ras-related Small GTP-binding Protein RhoB Is Immediate-early Inducible by DNA Damaging TreatmentsJournal of Biological Chemistry, 1995
- Structure and Expression of the Promoter for the Human Type II Transforming Growth Factor-β ReceptorBiochemical and Biophysical Research Communications, 1994
- Absence of transforming growth factor-β responsiveness in the tamoxifen growth-inhibited human breast cancer cell line CAMA-1Journal of Cellular Biochemistry, 1994